景峯醫藥(000908.SZ):中誠信國際決定將公司的主體信用等級調降至BBB
格隆匯8月17日丨景峯醫藥(000908.SZ)公佈,2021年8月7日,公司發佈公吿稱,截至當日末控股股東葉湘武持有公司14.79%的股份,其中2.08%(佔其所持股份比例為14.09%)已被貴州省貴陽市中級人民法院司法凍結,凍結起始日為2021年8月3日,到期日為2024年8月2日。截至8月10日,葉湘武及其一致行動人累計質押股份數佔其持股比例的52.66%。中誠信國際認為,葉湘武所持部分股份已被司法凍結,且其與一致行動人所持公司股份質押比例較高,對公司後續備用流動性的支持減弱。同時公司賬面貨幣資金較少,資金較為緊張,面臨很大的短期償債壓力。此外,“16景峯01”債券餘額為3.88億元,將於2021年10月27日到期,公司計劃通過處置資產進行債務償還,但目前資產處置進展較慢。
綜上所述,中誠信國際決定將湖南景峯醫藥股份有限公司的主體信用等級調降至BBB,將“16景峯01”的債項信用等級調降至BBB,並將主體和債項信用等級繼續列入可能降級的觀察名單。同時,中誠信國際將持續關注公司資產出售進展以及到期債務的償付資金籌措情況,並及時採取評級行動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.